Introduction
Human keratinocytes possess a finite proliferative lifespan but in contrast most advanced SCCs are immortal (Edington et al., 1995) . Analysis of the immortal phenotype has revealed several genetic alterations that are important to the process including the dysfunction of p53, INK4A and a gene on chromosome 3p that represses telomerase activity (Loughran et al., 1997; Parkinson et al., 1997) . In addition, microcell-mediated monochromosome transfer (MMCT) experiments suggest that other cancer mortality genes may exist (Casey et al., 1993; Hensler et al., 1994; Karlsson et al., 1996; Koi et al., 1993; Ning et al., 1991; Ogata et al., 1993; Rimessi et al., 1994; Sandhu et al., 1994 Sandhu et al., , 1996 Sasaki et al., 1994; Uejima et al., 1995; Wang et al., 1992) . Furthermore, loss of heterozygosity (LOH) at some of these other chromosomal loci, including the long arm of chromosome 4, supports a role for the dysfunction of these putative mortality genes in the immortality of human SCCs (Loughran et al., 1997) . Chromosome 4 has also been shown to carry a mortality gene(s) for cell lines mapping to mortality complementation group B (Ning et al., 1991) and a candidate for one of these genes, Mortality Factor 4 (MORF4), was described recently. However, MORF4 was excluded as a squamous cancer mortality gene on the basis of the absence of mutations and LOH leaving no functional evidence to link chromosome 4 to squamous cancer immortality. Therefore, we have used MMCT to test for a functional link between chromosome 4 LOH and SCC immortality. We took advantage of a panel of SCC lines which were characterized with respect to LOH (Loughran et al., 1997) and introduced the chromosome into lines that either did, or did not, show LOH of chromosome 4.
In lines with chromosome 4 LOH, re-introduction of chromosome 4 causes a phenotype reminiscent of crisis, which is independent of p53 and the INK4A locus and was not blocked by the ectopic expression of the catalytic subunit of telomerase (hTERT). We have mapped the mortality activity to a 2.7 Mb region of the chromosome and have examined the candidacy of the known genes in the region. Collectively, our results suggest the existence of a novel mortality gene at this locus and we discuss the possibility that it may also be a suppressor of some human cancers.
Results

Immortal human SCC-HN possess four consistent regions of LOH on chromosome 4
We previously reported that human SCC-HN lines show LOH on chromosome 4 (Loughran et al., 1997) and we have now extended this study by using one informative marker approximately every 10 cM (Figure 1a) . Figure  1a shows the results of LOH analysis with minimal regions of overlap (MRO) spanning D4S409 and D4S1089, D4S1089 and D4S1570, D4S1570 and D4S1565 and D4S1535 and D4S3032 . Examples are shown in Figure 1b . These regions are shown in more detail in Figure 1c . Although lines BICR6 and BICR78 were homozygous for the entire length of chromosome 4, there was no evidence for monosomy in any of the SCC-HN lines when they were examined by chromosome painting (data not shown).
Human chromosome 4 specifically restores mortality to SCC-HN lines with LOH on chromosome 4
It was unclear from the above which, if any, of these regions carried a suppressor of SCC-HN immortality. To address this question, we introduced a single normal copy of human chromosome 4 into two SCC-HN lines that possessed LOH on 4q, BICR6 and BICR31, and two cell lines that did not, BICR3 and BICR19. These cell lines are otherwise matched for p53 (Loughran et al., 1997), p16 INK4A (Loughran et al., 1997) , Ras (Clark et al., 1993) , epidermal growth factor receptor (Stanton et al., 1994) and chromosome 3 (Loughran et al., 1997) status (Table 1 ). All the lines are telomerase positive (Loughran et al., 1997) .
All the colonies that formed after the MMCT of human chromosome 4 looked essentially normal for four to 15 population doublings. However, after a variable number of population doublings, 39% of the HYTK4-BICR6 hybrids and 33% of the HYTK4-BICR31 hybrids began to show evidence of colony flattening (Figure 2a, b) and senescence associated bgalactosidase staining (Figures 2c,d ). This was followed several days later by multi-nucleation, the appearance of TUNEL-positive cells (P50.02; Figure 2e ,f) and detachment from the culture vessel. However, the mortal HYTK4-BICR6 cells were still able to incorporate BrdU in 48 h almost as well as immortal Figure 2g, h) showing that the mortal phenotype was more akin to crisis than senescence (Hahn et al., 1999; Stein, 1985) .
We were able to isolate 6 HYTK4-BICR6 colonies that showed features of a mortal phenotype before segregating an immortal phenotype. All of these hybrids were subjected to chromosome painting and shown to contain an extra copy of chromosome 4 that is not rearranged and apparently intact (data not shown). Microsatellite analysis of all six of these hybrids showed that the exogenous chromosome was indeed intact, at least at the level of one informative microsatellite approximately every 10 cM. These results illustrate that the hybrids displaying a phenotype following MMCT of chromosome 4 harbour an intact transferred chromosome.
We further examined the specificity of the chromosome 4 effect by transferring chromosome 4 into two closely matched target cell lines (Table 1) that had no LOH on chromosome 4. We also transferred other chromosomes into BICR6 (see below). It can be seen from Table 2a that only the cell lines with LOH on chromosome 4q to begin with, showed evidence of restored mortality when a normal copy of chromosome 4 was introduced. As there are multiple heterozygous markers in lines BICR3 and BICR19 within the D4S423-BIR0101 candidate region (see below and Figure 1c) , the lack of a phenotype in these lines adds weight to the specificity of the effect and argues against non-specific gene or chromosome dosage effects and/or the contamination of the exogenous chromosome 4 with other material. Furthermore, the introduction of normal copies of human chromosomes 3, 6, 11 and 15 (Table 2a) , or the HYTK construct (Lupton et al., 1991) into BICR6 (BICR6 HYTK -data not shown), was also without effect.
The chromosome 4 effect is not mediated by telomerase repression or telomeric attrition As the chromosome 4 mortality effect occurred following a considerable number of mean population doublings, we tested whether the chromosome carries a gene capable of repressing telomerase activity and/or precipitating telomeric attrition. First, we examined whether HYTK4-BICR6 hybrids still expressed telomerase activity when the hybrids were exhibiting signs of mortality. Hybrids exhibiting a limited lifespan showed clear telomerase activity as assessed by the TRAP assay, although it was reduced compared to the BICR6 controls (see Figure 3) . To investigate the role of telomerase repression more directly, we introduced hTERT into BICR6 and BICR31 by means of a retrovirus (Vaziri and Benchimol, 1998) and selected drug-resistant pools of hTERT-expressing clones. Figure 4 shows that these cells have extended their telomeres as expected for a cell population ectopically expressing hTERT (Vaziri and Benchimol, 1998) ; BICR6 and BICR31 have average TRF lengths of 3 and 6 -7 kb, respectively, which increase to around 10 -15 kb upon the ectopic expression of hTERT. The control cell lines used in this study, BICR3 and BICR19, had average TRF lengths of around 5 and 10 kb, respectively. TRF length was unaffected by the empty retroviral vector, or by drug selection. We then introduced chromosome 4 into these cells by MMCT and found that the percentage of colonies displaying the mortal phenotype was at least as high in the hTERTexpressing cells as in the empty vector and control cells (Table 2b ). Furthermore, there was no obvious change in the number of cell divisions completed prior to the appearance of mortal clones. Taken together, our results do not support the idea that the chromosome 4 mortality effect is mediated by the suppression of telomerase, or by the shortening of the telomeres of the target lines.
The characterization of the chromosome 4 sub-fragments and their effects on BICR6 Figure 5 shows the painting of the chromosome 4 fragments and their molecular characterization. The fragments 4i24, 4i30 and 4i33 were completely painted and showed no association with mouse chromosomal material (see Figures 5a -c were introduced into BICR6 by MMCT using the intact HYTK4 as a control, fragments 4i24 and 4i33, both of which lack most of the short arm of chromosome 4, were as potent at inducing mortality as the intact chromosome (Table 3 ). In addition 4i33 lacks a substantial portion of the long arm, therefore excluding candidate genes such as Mortality Factor 4 and the ING-related gene, ING1L (Shimada et al., 1998) , which map to 4q33 -q34.1 and 4q35.1, respectively. Fragment 4i30 was also active in the induction of the mortal phenotype when compared to the control chromosome 4. Fragment 4i30 contains a substantial portion of the dispensable short arm plus long arm markers to BIR0101 (4q23) making this latter (4cen -q23) region the minimal region shared by all three fragments. The assignment of the mortality gene(s) to the 4cen -q23 region was supported by the activity of fragment 4i32, which has only lost the portion of the long arm distal to D4S424. This data supports the conclusion gained from fragment 4i33 that Figure 4) 3 kb 6.5 kb 5 kb 10 kb the mortality gene(s) is not located between D4S424 and D4S3041. Significantly, this minimal 4cen -q23 region overlaps partially with the region of LOH detected in BICR31 (see Figure 1c) , making the likely candidate region D4S409 -BIR0101, if these two sets of data are combined.
The loss of exogenous chromosome 4 alleles is related to the segregation of the immortal phenotype
To further refine the position of the chromosome 4 mortality gene, we subjected 29 HYTK4-BICR6, 14 HYTK4i24-BICR6, 17 HYTK4i32-BICR6, 19 HYTK4i33-BICR6 and 11 HYTK4-BICR31 immortal Figure 3 Telomerase activities in mortal and immortal BICR6-chromosome 4 hybrids. Telomerase activity was detected by TRAP assay in mortal and immortal clones isolated from chromosome 4-BICR6 hybrids. For the parental cell lines and BICR6-chromosome 4 hybrid clones, 0.4 mg of cell extract were used per reaction and a heat inactivated control for each extract included. Each TRAP assay included a 36 bp internal standard to normalize for variation in PCR efficiency. TSR8 is the positive control from the kit. CHAPS is the extraction buffer alone (negative control). The cell lines investigated were BICR6 controls, BICR6 carrying the hygromycin B resistance gene alone (a control for the effects of hygromycin B), mortal BICR6-chromosome 4 hybrids no. 8 and no. 29 and immortal BICR6-chromosome 4 hybrid no. 7. The lanes marked HI are the corresponding extracts following heat treatment (a further negative control). The BICR6-chromosome 4 hybrids shown here are all from the same experiment and are distinct from those used for the mapping studies segregants to polymorphic microsatellite marker analysis. As controls, we also analysed 11 HYTK4-143B, 5 HYTK4-BICR3 and 6 HYTK4-BICR19 hybrids, which do not show a phenotype upon the introduction of chromosome 4. We also analysed 6 HYTK4-BICR6 mortal hybrids. None of these 28 control hybrids should lose the biologically relevant portions of chromosome 4 as frequently as the immortal segregants. Forty-nine out of 79 (62%) HYTK4-BICR6 and 10 of 11 (91%) HYTK4-BICR31 had lost at least one marker from the introduced chromosome compared with 8 of 28 (28%) Deletion analysis of immortal HYTK4-BICR segregants reveals a common region of exogenous chromosome 4 loss, flanked by markers D4S423 and BIR0101
The repeated loss of exogenous, wild type, chromosome alleles in immortal segregant clones arising from MMCT experiments can indicate that there is a suppressor of cancer cell proliferation (England et al., 1996) or viability (Robertson et al., 1998) in that chromosome region and can be used to map the position of the genes. This approach has been successfully used to map the gene responsible for Leigh Syndrome (Zhu et al., 1998) . Microsatellite analysis of the HYTK4-BICR6 and -BICR31 segregants, in the region 4cen -q23, revealed that 45 out of 90 (50%) had lost marker D4S423 (P50.03), 25 out of 79 (32%) had lost D4S409 (P=0.18), 37 out of 90 (41%) had lost D4S2964 (P=0.09) and 40 out of 90 (44%) had lost D4S1570 (P=0.06). The P values represent the probability that the losses at the microsatellites have occurred by chance, as assessed by comparing the frequency of loss in the immortal segregants with the frequency of loss in the control hybrids using the Fisher's Exact Test. This data suggests that the mortality gene may be located between D4S423 and D4S1570, but is more likely to be closer to D4S423. This interpretation is supported by the MMCT of the chromosome 4 fragments, which exclude much of the interval between D4S423 and D4S1570, with the exception of the region between D4S423 and the novel microsatellite marker BIR0101 ( Figure 5 ). Although 26% of the HYTK4-BICR6 immortal segregants had lost almost the entire copy of the introduced chromosome 4 (with the exception of the hygromycin B resistance marker) none of the segregants were monosomic for chromosome 4 as revealed by chromosome painting (data not shown). This argues against a reduction in modifier genes that might contribute to the mortal phenotype. A more detailed analysis revealed that 44 out of 79 (56%) HYTK4-BICR6 and six out of 11 (54.5%) HYTK4-BICR31 segregants had lost at least one microsatellite marker from the introduced chromosome, between D4S423 and the novel microsatellite marker BIR0101, with the greatest frequency of loss occurring at D4S3037, (P50.02; Figure 6 ). There were also frequent, and occasionally discrete, losses of the microsatellites BIR0104, D4S1557 and BIR0105. The positions of known genes mapping to this candidate interval are indicated on Figure 6 . We therefore tentatively place the mortality gene between D4S423 and BIR0101, a physical distance of approximately 2.7 Mb. Not all of the allelic deletions overlap, perhaps indicating intragenic deletions, or the loss of regulatory Figure 4 Ectopic expression of hTERT increases the average Terminal Restriction Fragment (TRF) length in BICR6 and BICR31 cells. Genomic DNA was isolated from cells, digested with RsaI and HinfI and separated on a 0.7% agarose gel before blotting onto Zeta-probe membrane. The blot was hybridized to a telomeric probe g-32 P-(TTAGGG) 3 and TRF lengths calculated as described in the Materials and methods. The cell lines studied are those used in all the MMCT experiments (BICR3, BICR6, BICR19 and BICR31) plus BICR6 and BICR31 infected with retroviruses carrying either the neomycin resistance gene alone (NEO) or the neomycin resistance gene plus the telomerase catalytic subunit gene hTERT (TERT). DNAs from the lines GM847, Hela and A1698 were used as controls for long, intermediate and short average TRF lengths, respectively. The high molecular weight BICR-specific band is not due to Swiss 3T3 contamination or incomplete digestion and is of unknown origin at present elements for one of the candidates. We found no evidence that the D4S423-BIR0101 region was a fragile site or unusually susceptible to recombination, since there were no breaks or discrete losses in this region when the 28 control hybrids were examined (data not shown).
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Discussion
Identification of a novel chromosome 4 locus associated with SCC-HN immortality
The present study follows previous observations showing a high frequency of LOH on the long arm of chromosome 4 in immortal neoplastic keratinocytes (Loughran et al., 1997) . First, we introduced chromosome 4 into SCC-HN lines with and without LOH on this chromosome (Loughran et al., 1997) and showed specific induction of the mortal phenotype in cell lines with LOH on chromosome 4 and only when chromosome 4 was transferred. The frequency of MMCT hybrids displaying a mortal phenotype was only around 40%. This is most likely explained by the relatively large fraction of the transferred chromosomes that harbour deletions of the candidate region (see below). However, it is also possible that the effectiveness of the re-introduced chromosome may be subject to clonal variation of the target cell population. Figure 6 Deletion analyses of immortal HYTK4-BICR6 segregants. (a) Map of exogenous chromosome marker loss in the 4cen -q23 region in selected HYTK4-BICR6 hybrid clones. Marker order is derived from the University of California at Santa Cruz draft human genome assembly (17/7/00 data freeze; http://genome.uscs.edu/). Significance of allele loss frequency compared to control hybrid clones is indicated for selected markers. This illustrates that the high frequency of loss between the markers D4S423 and BIR0101 is significant. The final column details the positions of known genes between D4S423 and BIR0101 relative to the markers in this region. (b) Example of allele loss and retention of microsatellite marker BIR0101 by the HYTK chromosome 4 in HYTK4-BICR6 hybrids Chromosome 4 fragment analysis mapped the activity crudely to D4S3045 -BIR0101, but subsequent deletion analysis of immortal clones resulting from the MMCT revealed a minimal region of loss of exogenous chromosome 4 alleles mapping to between D4S423 and BIR0101, within the D4S3045 -BIR0101 interval. This region excludes another candidate mortality gene, MORF4 , previously mapped to chromosome 4 (Ning et al., 1991) , suggesting that the region we have identified carries a novel gene involved in human cancer immortality.
Allele lost Allele retained Not informative Not informative
The candidate region may contain a suppressor of squamous tumorigenesis and other cancers in vivo Taken together our results suggest the existence of a squamous cancer mortality gene in the region of D4S423 -BIR0101 and there is evidence that this region may also contain a suppressor of squamous tumorigenesis. Immortality is known to be an early event in multistage oral cancer, detectable at the dysplasia stage (McGregor et al., 1997) , and comparative genomic hybridization has shown that a similar fraction of these lesions show a loss of chromosome 4q. Moreover, LOH has been reported within our candidate region at higher than background frequencies in squamous cell carcinoma of the head and neck (Pershouse et al., 1997; Shah et al., 2000; Wang et al., 1999) . There is also strong evidence to link a 24 Mb region, spanning our region, with Huriez syndrome (MIM 181600), a heritable skin disorder which can predispose to squamous cell carcinoma of the skin and perhaps other tissues . The unknown mortality gene we have mapped and the unidentified Huriez syndrome gene may not be the same, but there are other examples of tumour suppressor genes that appear to have a role in the control of human cancer immortality (Loughran et al., 1997) .
LOH, including the interval we have defined, has also been reported in cases of carcinoma of the oesophagus (Hu et al., 2000; Rumpel et al., 1999) , cervix (Mitra et al., 1994) and liver (Bluteau et al., 2002; Buetow et al., 1989) . In addition, a comparative genomic hybridization study of small cell cancer of the lung revealed loss of the 4q11 -q23 region in 86% of cases (Petersen et al., 1997) and the same technique has revealed the loss of chromosome 4q in breast (Tanner et al., 1998) colon (Arribas et al., 1999) and prostate (Virgin et al., 1999) carcinoma. Moreover, a hemizygous 8 cM germline deletion spanning our region was also shown to be associated with hepatic cancer (Terada et al., 2001) .
Chromosome 4 induces M2 crisis independently of telomerase, telomere length, p53 and INK4A
Analysis of the mortal phenotype, using classical criteria such as the ability to incorporate BrdU in a 48 h period, showed that the mortal clones did not fulfil the definition of senescent cultures (Stein, 1985) . However, the mortal hybrids were considerably less efficient in incorporating BrdU in this period (P50.05). TUNEL staining also revealed much higher levels of apoptosis in the mortal hybrids than either the immortal hybrids or the control BICR6 cells (P50.02). Thus the phenotype displayed by the mortal BICR6 MMCT hybrids fulfilled the definition of cells in crisis (Hahn et al., 1999; Stein, 1985) , rather than cells entering the irreversible G1 cell cycle checkpoint associated with replicative senescence (Stein, 1985) .
The molecular function of the mortality gene we have mapped is unknown, but the presence of a lag between the transfer of chromosome 4 and the appearance of a phenotype related to crisis would be consistent with a repression of telomerase and the shortening of the telomeres to a length sufficient to engage crisis (Hahn et al., 1999; Stein, 1985) . However, our data showed that telomerase activity is retained in the HYTK4-BICR6 clones, even when they are displaying a mortal phenotype. Also, the experimental lengthening of the BICR6 and BICR31 telomeres to 410 kb following the ectopic expression of hTERT, failed to block the effect of chromosome 4 in these lines. These data suggest that the chromosome 4 effect is not mediated by telomeric attrition or by the suppression of telomerase and also argue against other telomerase-mediated effects such as an inhibition of telomere capping (Zhu et al., 1999) , for example. Our results are therefore in apparent contrast to a recent report that suggested chromosome 4 mediates the mortality of Hela cells by repressing telomerase (Backsch et al., 2001) , but some results indicate that the gene(s) causing SCC and Hela mortality are distinct . Nevertheless, we cannot rule out the possibility that the unknown chromosome 4 gene inhibits capping by a telomerase-independent mechanism, or that it affects telomerase function in vivo. It is, therefore, not possible to say that the chromosome 4 gene(s) works by a telomere-independent mechanism at this stage.
The action of chromosome 4 also appears to be independent of p53 and the genes encoded by the INK4A locus as p53 is mutated and INK4A is homozygously deleted in both BICR6 and BICR31 (Loughran et al., 1997) .
Candidate genes in the region
Four known genes have been identified in the D4S423 -BIR0101 candidate interval. The GRID2 gene (Hu et al., 1998 ) encodes a glutamate receptor ion channel expressed in the cerebellum. ATOH1 (Ben-Arie et al., 1996) encodes the human homologue of the Drosophila 'atonal' gene product. It is a basic helixloop -helix domain-containing molecule that is proposed to play an important role in the development of the sensory epithelia of the inner ear. PGDS (Kanaoka et al., 1997) produces the haematopoietic version of the enzyme prostaglandin D synthase. The limited (non-skin epithelial) expression patterns of these three genes suggest that they are unlikely candidates for a mortality gene disrupted in SCC tumours. The fourth gene, ETL1, however, shows relatively ubiquitous expression. It is the human homologue (HUGO locus name SMARCAD1; (Adra et al., 2000) ) of murine etl1 (Soininen et al., 1992) . It is a molecule containing a SNF2 related domain, suggesting a role in ATP driven chromatin remodelling. Although ETL1 is only targeted by 14 out of 20 of the deletions in the most informative segregants and by only one of the three small, discrete deletions ( Figure  6 ), we are currently assessing its candidacy.
To date, we have found no somatic mutations in ETL1 in any SCC lines, including all the targets of the monochromosome transfer experiments described above. Northern blot analysis showed that BICR6 and BICR31 had a twofold lower level of ETL1 expression than normal keratinocytes and the control lines BICR3 and BICR19 (N Barr, unpublished data), raising the possibility that a small reduction in the dosage of the gene could contribute to the immortality of these lines. However, it is equally possible that another, as yet unidentified, gene spanning BIR0104 and BIR0105 is responsible for the mortality effect of chromosome 4. The genome sequence for this region is now finished, which will aid the discovery of further genes to test as candidates.
In summary, the identification of the chromosome 4 mortality gene described here may well identify additional pathways that must be disrupted in the immortalization of human cancer cells.
Materials and methods
Cell cultures
The biological (Edington et al., 1995) and genetic (Loughran et al., 1997) properties of the neoplastic keratinocyte cultures and lines used in this study have been described previously and the key points are summarized in Table 1 . The keratinocytes were cultured using Swiss 3T3 feeder layers also as described previously (Edington et al., 1995; Loughran et al., 1997) . Human fibroblasts taken from the same patients and used as a source of normal DNA (Edington et al., 1995; Loughran et al., 1997) were cultured in Dulbecco's Modified Eagle's Medium (DMEM) plus 20% foetal bovine serum (FBS). Mouse A92 cells containing a single copy of human chromosome 4 carrying the selectable markers for hygromycin B and G418 resistance (HYTK4; (Cuthbert et al., 1995; Lupton et al., 1991) ) were grown in DMEM plus 10% FBS and 800 units/ml hygromycin B (Calbiochem Novachem (UK) Ltd.). The osteosarcoma line, 143B, was used as a control recipient owing to its inability to senesce following the introduction of a normal human chromosome 4 (Ning et al., 1991) . 143B was cultured in the same medium as A92 cells but without hygromycin B. The cell lines GM847, A1698 and Hela were also cultured in DMEM plus 10% FBS.
Microcell-mediated monochromosome transfer (MMCT)
Microcells were prepared as described previously (Cuthbert et al., 1995) and the purified microcell pellet was then resuspended in 50 mg/ml phytoheamagglutinin in serum-free medium and applied to 70 -80% confluent recipient cells.
Plates were left for 2 h to allow attachment of microcells before fusion to the recipient cells in the presence of 42.5% polyethylene glycol (PEG 1000, Sigma) and 8.5% DMSO in serum-free medium. In later experiments the use of 21% PEG and 4% DMSO in the presence of the phytoheamagglutinin was found to increase the hybrid yield substantially. Following a 24 h recovery period in complete medium, fused cells were re-plated in standard medium for 3 -4 days prior to selection in medium containing 60 (BICR3 and BICR31), 80 (BICR19) and 125 (BICR6) units/ml hygromycin B. Doses represented the minimum required for complete killing of mock fused cultures of each line and hence the minimum dose required. The careful selection of drug dose avoids artefacts due to incomplete hygromycin resistance. Those colonies, which overcame selection in hygromycin B, were picked and cultured for a further 5 -6 weeks before harvesting and extracting DNA. An immortal segregant chromosome 4 hybrid culture was classified as one that proliferated through at least 20 population doublings and the control hybrids were cultured for the same number of doublings prior to molecular genetic analysis. The immortal segregants were all maintained in the appropriate dose of hygromycin.
Preparation and characterization of chromosome 4 subfragments
Microcells were prepared from the HYTK4 cells as described above and they were irradiated with 0.25, 0.5 and 1.0 Gy of g rays from a cobalt source at a dose rate of 1.5 Gy per min. Higher doses of radiation caused complete fragmentation of the chromosomes. The microcells were then transferred into new A92 background cells as described previously (Cuthbert et al., 1995) . The A92-chromosome hybrid cells were selected on hygromycin (800 U/ml) and then checked for dual resistance to G418 (1 mg/ml). Colonies that were resistant to both compounds were likely to contain large fragments of chromosome 4 material, although some of the fragments used were only resistant to hygromycin. Chromosome painting showed that three out of the four fragments used were completely painted and were not obviously fused with mouse material. Microsatellite analysis was used to determine the integrity of each fragment (see results).
Microsatellite analysis
DNA was extracted from 10 6 -10 7 cells using the QIAamp tissue kit (QIAgen Ltd., Crawley, West Sussex, UK) according to the manufacturer's 'blood and body fluid' protocol.
Total reaction volumes were 10 ml containing 40 ng genomic DNA, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 10% dimethylsulphoxide, 1 mM of each oligonucleotide primer, 200 mM concentrations of each deoxynucleotide triphosphate, 0.4 ml of [a 32 P]dCTP (24.7 kBq/ml) and 0.5 units of Taq polymerase (Advanced Biotechnologies). Reactions were subjected to an initial denaturation phase of 5 min at 948C, followed by 30 cycles of 30 s at 948C; 30 s at 55 -658C; and 30 s at 728C, and a final extension phase of 7 min at 728C. Radiolabelled samples were electrophoresed on 4 -10% polyacrylamide gels under denaturing conditions. Following a drying step, gels were then exposed to X-ray film to visualize the resolved reaction products. Novel microsatellite sequences were identified from draft human genome sequences from the chromosome 4q21 -q23 candidate interval. Below is a list of informative novel polymorphic markers which we developed for this analysis. Details of each marker are listed in the form: Marker name; Forward primer; Reverse Primer; Repeat type; PCR annealing temperature; PCR product size (approximate): BIR0101; 5'-TGTACTTTGT GAGATCCACC-3'; 5'-TTGCCCATCT TTTGATCAGC-3'; CA/TG; 558C; 264 bp: BIR0103; 5'-AGTTGCCTGG AAAGAAGTGG-3'; 5'-GTCGACTTAA CTATAGCTGC-3'; AAC/GTT; 608C; 202 bp: BIR0104; 5'-GTTTTGAGAC AGGGTCTTGC-3'; 5'-AACCTTCTCC AGCTTGAACC-3'; ATT/AAT; 638C; 194 bp: BIR0105; 5'-AACAGGTAAA GGTGCCACAC-3'; 5'-AACAAATCTG CACGCTGTGC-3'; TTA/TAA; 608C; 125 bp: BIR0108; 5'-ATGTACTCTT GCCTCACAGC-3'; 5'-TGCAGTTCCA GAAACATGTGC-3'; CA/TG; 608C; 199 bp: BIR0109; 5'-GAGGGATCAT GTTATCTTGC-3'; 5'-TTGCAGTGAG CCAAGATTGC-3'; ATTT/AAAT; 608C; 188 bp.
Statistical analyses
To test the statistical significance of quantitative data the Wilcoxon -Mann -Whitney non-parametric rank test was used (Snedecor and Cochrane, 1973) .
The Fisher's Exact Test was used for the comparison of allele deletion frequencies in different groups of cells. In the case of the immortal segregant colonies resulting from the MMCT of the HYTK4 chromosome, the allele deletion frequencies of the transferred, wild type, HYTK4 chromosome were compared with the deletion frequencies of the same allele in a panel of control HYTK4 hybrids. The control panel of hybrids comprised of 6 HYTK4-BICR6 hybrids that displayed a mortal phenotype, 6 HYTK4-BICR19 hybrids, 5 HYTK4-BICR3 hybrids and 11 HYTK4-143B hybrids. The last three hybrid sets were fusions that never resulted in a mortal phenotype. All of these control fusions therefore constitute a measurement of the spontaneous loss of each allele of the transferred chromosome that may not be consistent throughout the length of the chromosome.
Chromosome painting
Metaphase chromosome spreads were prepared essentially as described by Cuthbert et al. (1995) . Metaphase spreads were hybridized with a chromosome 4 probe prepared from flowsorted chromosome 4 DNA and chromosome painting carried out as described previously (Cottage et al., 2001) .
BrdU labelling and TUNEL staining
BICR6 cells and MMCT hybrids were plated into 8-well chamber slides (Labtek, UK) at a density of 280 cells per cm 2 in the absence of Swiss 3T3 feeder cells. Under these conditions the BICR6 line normally replicates efficiently and grows to confluence. The MMCT HYTK4-BICR6 hybrids were plated for analysis 6 weeks after MMCT and were cultured for 6 days further in the absence of 3T3 cells before analysis.
BrdU incorporation analysis was undertaken using the 5-Bromo-2'-deoxy-uridine Labelling and Detection Kit 1 (Boehringer Mannheim). Reagents were supplied as kit components. BrdU was added to the sample at a final concentration of 10 mm diluted in sterile cell culture medium. The cells were then incubated for 48 h at 378C. Cells incorporating BrdU were then detected with an anti-BrdU mouse monoclonal antibody and indirect immunofluorescence according to the manufacturers instructions. TUNEL analysis was undertaken using the Apoptag 1 fluorescein direct in situ apoptosis detection kit (Intergen Company) following fixation of the cells with 1% paraformaldehyde in PBS, pH 7.4, for 10 min at room temperature and post-fixation with pre-cooled Ethanol/Acetic Acid for 5 min at 7208C.
Retrovirus production and ectopic expression of hTERT
The neomycin-resistance-tagged hTERT and empty vector control retroviruses were produced by transfecting the amphotropic packaging line Phoenix A (Vaziri and Benchimol, 1998 ) with pBabeNeo or pBabest2 (Vaziri and Benchimol, 1998) and selecting with G418. When the cells were 80% confluent, they were fed with medium lacking G418 and the supernatants were recovered, filtered, and frozen 24 h later. The BICR6 and BICR31 cells were plated at 4610 5 per 5 cm dish and infected 24 h later at a multiplicity of one infectious unit per cell in the presence of 4 -8 mg/ml of polybrene. Twenty-four hours later the cells were disaggregated and seeded at 3610 5 per 9 cm plate with G418-resistant Swiss 3T3 cells and selected 48 h later with 200 (BICR31) and 600 (BICR6) mg/ml of G418 for 2 -3 weeks. Pooled G418-resistant colonies were used in all experiments to avoid variation due to clonal heterogeneity of the population.
Telomere length measurement
Genomic DNA was extracted using a Nucleon BACC kit (Nucleon Biosciences, UK) following the manufacturer's instructions. For telomere length comparisons, 5 mg of genomic DNA was digested to completion with RsaI and HinfI restriction enzymes, separated on a 0.7% w/v agarose gel, and transferred to Zeta-Probe GT membrane (Bio-Rad Laboratories, UK) in 0.4 N NaOH transfer buffer. The blot was hybridized with a radiolabelled oligonucleotide probe (TTAGGG) 3 at 428C and subsequently washed to a stringency of 66SSC/1%SDS at 428C.
The telomere lengths were measured by calculating the relative front values using a Bio-Rad molecular imager and Quant One imaging software.
Telomerase activity
Cellular extracts were prepared and assayed for telomerase activity using the TRAPeze kit (Intergen, Company, UK) following the manufacturer's instructions. The PCR products were resolved on 10% non-denaturing polyacrylamide gel. To semi-quantitate telomerase activity, we measured the ratio of the 36 bp internal standard to the telomerase ladder. The intensity of the bands were measured using the Bio-Rad molecular imager and quantitated by Quant One imaging software.
